Brett Matthew Hall, CHIEF SCIENTIFIC OFFICER at Immuneering Corp (IMRX), bought 13,211 shares at $2.86 ($30K) on 2024-03-20, disclosed to the SEC on 2024-03-21.
Open-market purchase of $30k IMRX by CHIEF SCIENTIFIC OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.62 | 6,211 | $10K | 33.4% |
| 2 | $2.86 | 7,000 | $20K | 66.6% |
| Total | $2.28 avg | 13,211 | $30K | 100% |
| Filing → |
| IMRX | BUY | 2025-06-24 | $35K | — | Filing → |
| IMRX | BUY | 2022-05-27 | $10K | — | Filing → |
| IMRX | BUY | 2022-03-23 | $8K | — | Filing → |